Ads

 

Ads

 

Ads

 

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026

World Top 100 HealthCare Products Companies List by Market Cap as of August 2026, World Biggest 100 HealthCare Products Companies by Market Cap, World Largest 100 HealthCare Products Companies in the World by market cap as of August 2026.

Metatag Title
World Largest HealthCare Products Companies in 2026
Metatag Abstract
World Top HealthCare Products Companies by Market Cap in 2026, World Largest HealthCare Products Companies by Market Cap in 2026.
  1. ADMA Biologics

    World Rank (Aug-2026)
    6,140
    Market Cap (Aug-2026)
    2.121 Billion USD
    World Rank (Jan-05-2024)
    8,463
    Market Cap (Jan-05-2024)
    1.024 Billion USD
    World Rank (Jul-30-2023)
    9,311
    Market Cap (Jul-30-2023)
    0.896 Billion USD
    World Rank (Dec-25-2022)
    9,556
    Market Cap (Dec-25-2022)
    0.806 Billion USD
    World Rank (Jan-07-2022)
    17,664
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    510 Million USD
    Annual Operating Income in USD
    191 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
  2. Neuren Pharmaceuticals

    World Rank (Aug-2026)
    6,165
    Market Cap (Aug-2026)
    2.100 Billion USD
    World Rank (Jan-05-2024)
    5,527
    Market Cap (Jan-05-2024)
    2.090 Billion USD
    World Rank (Jul-30-2023)
    8,222
    Market Cap (Jul-30-2023)
    1.112 Billion USD
    World Rank (Dec-25-2022)
    10,227
    Market Cap (Dec-25-2022)
    0.715 Billion USD
    World Rank (Jan-07-2022)
    15,657
    Market Cap (Jan-07-2022)
    0.36 Billion USD
    Headquarters Country
  3. Harbin Pharmaceutical Group

    World Rank (Aug-2026)
    6,193
    Market Cap (Aug-2026)
    2.083 Billion USD
    World Rank (Jan-05-2024)
    7,753
    Market Cap (Jan-05-2024)
    1.190 Billion USD
    World Rank (Jul-30-2023)
    7,926
    Market Cap (Jul-30-2023)
    1.179 Billion USD
    World Rank (Dec-25-2022)
    7,762
    Market Cap (Dec-25-2022)
    1.138 Billion USD
    World Rank (Jan-07-2022)
    7,855
    Market Cap (Jan-07-2022)
    1.37 Billion USD
    Headquarters Country
  4. Aurinia Pharmaceuticals

    World Rank (Aug-2026)
    6,240
    Market Cap (Aug-2026)
    2.058 Billion USD
    World Rank (Jan-05-2024)
    7,666
    Market Cap (Jan-05-2024)
    1.213 Billion USD
    World Rank (Jul-30-2023)
    6,232
    Market Cap (Jul-30-2023)
    1.755 Billion USD
    World Rank (Dec-25-2022)
    10,850
    Market Cap (Dec-25-2022)
    0.644 Billion USD
    World Rank (Jan-07-2022)
    5,556
    Market Cap (Jan-07-2022)
    2.44 Billion USD
    Annual Revenue in USD
    35 Million USD
    Annual Net Income in USD
    -138 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Aurinia Pharmaceuticals is a Clinical Stage Biopharmaceutical company. The company developing in voclosporin, an investigational therapy for the treatment of lupus nephritis and other proteinuric diseases. The headquarters is in Canada.
  5. NeoGenomics Inc.

    World Rank (Aug-2026)
    6,256
    Market Cap (Aug-2026)
    2.048 Billion USD
    World Rank (Jan-05-2024)
    5,578
    Market Cap (Jan-05-2024)
    2.053 Billion USD
    World Rank (Jul-30-2023)
    5,407
    Market Cap (Jul-30-2023)
    2.202 Billion USD
    World Rank (Dec-25-2022)
    7,690
    Market Cap (Dec-25-2022)
    1.158 Billion USD
    World Rank (Jan-07-2022)
    4,374
    Market Cap (Jan-07-2022)
    3.45 Billion USD
    Annual Revenue in USD
    727 Million USD
    Annual Operating Income in USD
    -116 Million USD
    Annual Net Income in USD
    -108 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    NeoGenomics is a Premier Cancer Diagnostics and Pharma Services company. It is a serving oncologists, pathologists, pharmaceutical companies, academic centers and others with innovative diagnostic, prognostic and predictive testing. The company support clients in many cancer related market segments including hospital and private pathology laboratories, office based oncologists, academic institutions, contract research and pharmaceutical development organizations. The headquarters is in USA.
  6. Caplin Point Laboratories

    World Rank (Aug-2026)
    6,276
    Market Cap (Aug-2026)
    2.032 Billion USD
    World Rank (Jan-05-2024)
    7,323
    Market Cap (Jan-05-2024)
    1.320 Billion USD
    World Rank (Jul-30-2023)
    9,896
    Market Cap (Jul-30-2023)
    0.804 Billion USD
    World Rank (Dec-25-2022)
    10,820
    Market Cap (Dec-25-2022)
    0.647 Billion USD
    World Rank (Jan-07-2022)
    10,208
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Annual Revenue in USD
    158 Million USD
    Annual Net Income in USD
    38 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
  7. Agios Pharmaceuticals

    World Rank (Aug-2026)
    6,312
    Market Cap (Aug-2026)
    2.004 Billion USD
    World Rank (Jan-05-2024)
    7,260
    Market Cap (Jan-05-2024)
    1.340 Billion USD
    World Rank (Jul-30-2023)
    6,950
    Market Cap (Jul-30-2023)
    1.477 Billion USD
    World Rank (Dec-25-2022)
    6,594
    Market Cap (Dec-25-2022)
    1.485 Billion USD
    World Rank (Jan-07-2022)
    6,755
    Market Cap (Jan-07-2022)
    1.77 Billion USD
    Annual Revenue in USD
    54 Million USD
    Annual Operating Income in USD
    -472 Million USD
    Annual Net Income in USD
    -413 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Bio-pharmaceutical company with headquarters is in Massachusetts, USA.
  8. Zhejiang Hisun Pharmaceutical

    World Rank (Aug-2026)
    6,332
    Market Cap (Aug-2026)
    1.995 Billion USD
    World Rank (Jan-05-2024)
    6,454
    Market Cap (Jan-05-2024)
    1.625 Billion USD
    World Rank (Jul-30-2023)
    5,948
    Market Cap (Jul-30-2023)
    1.889 Billion USD
    World Rank (Dec-25-2022)
    5,722
    Market Cap (Dec-25-2022)
    1.849 Billion USD
    World Rank (Jan-07-2022)
    5,371
    Market Cap (Jan-07-2022)
    2.59 Billion USD
    Annual Revenue in USD
    1,766 Million USD
    Annual Net Income in USD
    71 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  9. Tibet Rhodiola Pharmaceutical Holding

    World Rank (Aug-2026)
    6,363
    Market Cap (Aug-2026)
    1.982 Billion USD
    World Rank (Jan-05-2024)
    6,404
    Market Cap (Jan-05-2024)
    1.642 Billion USD
    World Rank (Jul-30-2023)
    5,896
    Market Cap (Jul-30-2023)
    1.921 Billion USD
    World Rank (Dec-25-2022)
    7,270
    Market Cap (Dec-25-2022)
    1.274 Billion USD
    World Rank (Jan-07-2022)
    6,220
    Market Cap (Jan-07-2022)
    2.04 Billion USD
    Annual Revenue in USD
    311 Million USD
    Annual Net Income in USD
    30 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  10. NovoCure Limited

    World Rank (Aug-2026)
    6,373
    Market Cap (Aug-2026)
    1.974 Billion USD
    World Rank (Jan-05-2024)
    6,926
    Market Cap (Jan-05-2024)
    1.443 Billion USD
    World Rank (Jul-30-2023)
    3,876
    Market Cap (Jul-30-2023)
    3.539 Billion USD
    World Rank (Dec-25-2022)
    1,903
    Market Cap (Dec-25-2022)
    7.661 Billion USD
    World Rank (Jan-07-2022)
    2,542
    Market Cap (Jan-07-2022)
    6.88 Billion USD
    Annual Revenue in USD
    535 Million USD
    Annual Net Income in USD
    -58 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile

    Manufactures medical equipment related to treating tumors. Headquarters is in Jersey.

Share

Ads